The Nutrini Range

This information is intended for Healthcare Professionals only.

The Nutrini range is a portfolio of nutritionally complete paediatric tube feeds, designed to support the dietary management of disease‑related malnutrition and growth failure in children who require enteral nutrition.

Formulated for children from 1-6 years of age or 8-20kg body weight, the Nutrini range supports a wide variety of clinical needs, feeding routes and energy requirements, helping healthcare professionals deliver individualised tube‑feeding regimens with confidence.

Supporting Paediatric Tube Feeding with Nutrini

The Nutrini range offers age‑appropriate, nutritionally complete feeds that can be used as a sole source of nutrition or as a supplement to oral intake, depending on clinical needs.

All Nutrini products are:

  • Foods for Special Medical Purposes
  • Designed for enteral feeding
  • ACBS approved
  • Must be used under medical supervision

The Nutrini range enables healthcare professionals to tailor tube‑feeding plans according to:

  • Age and body weight
  • Energy and protein requirements
  • Gastrointestinal tolerance
  • Route of feeding (bolus or continuous)
  • Long‑term or transitional nutrition needs

Used alongside Nutricia’s Flocare™ feeding devices and tube‑feeding support resources, Nutrini helps support safe and effective enteral nutrition in children. 

Discover the Nutrini Range

PIONEERING EXCELLENCE IN PAEDIATRIC ENTERAL NURITION

  • Widest range to suit patient needs1
  • The only range with a whey dominant protein blend1 which is associated with fewer episodes of vomiting and reflux in tube fed children2-6
  • The only range of extensively hydrolysed protein feeds1
  • MF6 fibre blend to help maintain gut health7
  • Aligned with international guidelines for EPA† and DHA §8
  • Broadest range of fibre and carotenoid to mimic western diets9-12

Nutrini & Nutrini Multi Fibre

The only paediatric tube feeds1 with a unique whey-dominant formulation for improved tolerance2-5, MF6 fibre blend to help improve bowel health6-11 and a unique DHA dominant blend of LCPs.13-15

Nutrini Low Energy Multi Fibre

Nutrini Energy & Nutrini Energy Multi Fibre

Energy-dense 1.5kcal/ml tube feeds for children with higher nutritional requirements, available with and without added fibre.  

Delivers essential fatty acids DHA and EPA* in line with international recommendations16-17 and offers the most diverse sources of fibre and carotenoids to mimic a healthy Western diet9-11,16-17.

*DHA and EPA levels along with the nutritional formulations of feeds, are correct as of February 2026. 

Nutrini Peptisorb & Nutrini Peptisorb Energy

45% of patients with gastrointestinal disorder (GI) experience malnutrition18

Feed intolerance, maldigestion and malabsorption can result in complications and negative outcomes including poor growth and development, discomfort and pain, and a reduced quality of life19, 20-21

Children with major chronic illnesses often have symptoms which can lead to difficulties tolerating feed19-20, 23-25

Discover our sub-range of 100% whey based extensively hydrolysed protein tube feeds for children with faltering growth and malabsorption and/or maldigestion.

100% whey based extensively hydrolysed protein offers a physiological absorptive advantage26-30 with a specifically tailored & optimal fat blend to support tolerance whilst promoting gut adaptation31-37

100% whey protein aids digestion and tolerance38, increases gastric emptying4, 39-40 and reduces the frequency of vomiting41.

Request a visit with a Nutricia representative

Important Notice

The products in the Nutrini range are Foods for Special Medical Purposes for the dietary management of disease-related malnutrition and must be used under medical supervision.

*Product can be provided to patients upon the request of a healthcare professional. They are intended for the purpose of professional evaluation only.

† Eicosapentaenoic acid     

§ Docosahexaenoic acid 

  1. MIMS UK & Ireland, June 2026. 
  2. Billeaud C et al. Eur J Clin Nutr. 1990;44(8):577–583. 
  3. Tolia V et al. J Pediatr Gastroenterol Nutr. 1992;15:297–301. 
  4. ried MD et al. J Pediatr. 1992;120(4 Pt1):569–572. 
  5. Brun AC et al. Clin Nutr. 2011. 
  6. Meyer R et al. BMC Gastroenterol. 2015;15:137. 
  7. Silk, et al. J Clin Nutr. 2001;20(1):49-58.3.
  8. Kris-Etherton PM, Grieger JA, Etherton TD. Dietary reference intakes for DHA and EPA. Prostaglandins Leukot Essent Fatty Acids. 2009;81(2-3):99-104. doi:10.1016/j.plefa.2009.05.011. 
  9. Vaisman N et al. Clinical Nutrition 2006; 25:106. 
  10. Green CJ. Clin Nutr. 2001;20:23–39. 
  11. Guimber D et al. J Pediatr Gastroenterol Nutr. 2007. 
  12. Hoffman et al. Clin Nutr 2001;20:63.      
  13. SACN, Advice on fish consumption: benefits & risks. 2004, Scientific Advisory Committee on Nutrition: London. 
  14. Williams CM. et al. Proc Nutr Soc. 2006;65:42-50.  
  15. Eilander A. et al. Prostaglandins Leukot Essent Fatty Acids.2007;76:189-20. 
  16. EFSA NDA Panel, EFSA J 2010; 8: 1461.
  17. UK SACN, Scientific Advisory Committee on Nutrition, 2004. 
  18. Meijers, et al. The British Journal of Nutrition 2009;101:417-23.  
  19. Shaw V (Editor) Clinical Paediatric Dietetics, 4th Edition November 2014. Wiley-Blackwell.
  20. Campanozzi A et al. Brain Dev. 2007; 29(1): 25-9. 
  21. Gupta GL et al. Arch Dis Child 2006; 91 (3): 259-264. 
  22. Barr RD Nutrition 2002; 18 (5); 434-435. 
  23. Rogers EJ et al. Nutrition. 2003; 19(10): 865-8.  
  24. Dziekiewicz MA et al. Adv Exp Med Biol. 2015; 873: 1-7.  
  25. Del Giudice E et al. Brain Dev. 1999; 21(5): 307-11.
  26. Vanderplas et al. J Paediatric Gastroenterol. Nutr, 2014. 58 (5): 549-552. 
  27. Peptide size distribution and free amino acid analysis (data on file, June 2021). 
  28. Goulet et al. Clin Nutr. 2013 32 (2) : 162 -171.
  29. Grimble at al. Amino acid metabolism and therapy in health and nutritional disease. 1995, 319-336.  
  30. Grimble et al. Gastroenerol. 1987. 92(1): 136 -142. 
  31. Braeggar et al. J Paediatr. Gastroenterol. Nutr. 2010, 511:110-122.  
  32. Neelis et al. Best Pract. Res. Clin. Gastroenterol, 2016, 302 : 249-261.
  33. Olieman. Nutrients, 2020. 121, 177.  
  34. Sijben et al. Clin Nutr, 2011, 303 : 272-81.  
  35. Widenhorn-Muller et al. Prostaglandins Leukot Essemt Fatty Acids 2014. 91 : 49-60.  
  36. EFSA NDA Panel, 2014.  
  37. Sadowska et al. Applied Sciences. 2020. 10 (21): 7663. 
  38. Alexander DD et al. World J Gastrointest Pharmacol Ther. 2016; 7(2): 306-19. 
  39. Khoshoo V et al. Eur J Clin Nutr. 2002; 56(7): 656-8.  
  40. Meyer R et al. BMC Gastroenterol. 2015; 15: 137.
  41. Khoshoo V et al. 1996 22(1): 48-55.
  42. Watling R et al. Poster. BSPGHAN, 2008. 
  43. Sorensen K, et al. Poster: ESPGHAN, 2017.

 

Nutricia offers access to a wide range of support services and resources including:

  • • Our free Sampling Service to order product samples and have them sent to your patients' homes.
  • • A range of CPD accredited e-learning programmes.
  • • Order free paper copies of our support tools for yourself or to use with your patients.
  • • Sign up to receiving marketing communications and be the first to know about our free educational events & webinars, the latest scientific research and product updates.
Register today for free
Nutricia logo
background-footer-no-logo

Also on this website

Follow us on LinkedIn

Follow us on Twitter

  • Nutricia Ireland Limited is a company registered in the Republic of Ireland with company number 106997. VAT Number IE4800652P
  • © 2024 Nutricia. All rights reserved
x